Key HighlightsNet income was USD 0.2 million (USD 237 thousand) in the third quarter ended September 30, 2026, against a net loss of USD 2.4 million a year earlier, withEarnings Per Shareof USD 0.00 versus a loss of USD 0.04.A USD 2.6 million refund …
Key HighlightsRevenue rose 7.8% to USD 22.2 million in the third quarter ended September 30, 2026, from USD 20.6 million a year earlier, led by contract research and distributorDemandin the Americas and Asia Pacific.GAAP net loss was USD 2.6 million, or USD 0.58 per …
The company holds SOL as a treasury asset and earns staking rewards, while also running validator infrastructure and advisory services in Asia Pacific.Revenueof USD 3.4 million included staking revenue of USD 3.3 million on 30,767 SOL earned. Third-party stake on its Pacific Backbone validator …
The upgrade is built around dated milestones rather than bitcoin prices. The first is credit support at Rockdale, which would show lenders and tenants are willing to underwrite the site. The second is financing for Corsicana expected in 2027, which would let the company …
Key HighlightsSymvess sales rose 151% from the second quarter to slightly over USD 1 million in the third quarter ended September 30, 2026, management said, against USD 0.7 million in the third quarter of 2025.The net loss was USD 15.5 million, or USD 0.06 …
Underneath the gain, the core operation weakened. Revenue of USD 164.2 million fell 34.9% from a year earlier and missed the USD 176.1 million forecast. The company attributed about USD 94.8 million of the decline to a 37% drop in the average price of …
The company develops KARNO power modules, additively manufactured generators aimed at military,Data Centerand prime power uses. Management said it expects about USD 50 million of new military awards for 2026, including a USD 41.7 million Navy contract from July and two pending awards of …
Two factors support the higher outlook. First, demand for hybrid vehicles remains robust. Toyota is the global leader in hybrids, and consumers concerned about fuel prices and charging infrastructure have kept buying them, which helps volume and gives the company a product mix that …
The company uses an AI-enabled antibody discovery platform to develop treatments for obesity and related cardiometabolic and cardiopulmonary conditions. It dosed the first participant in a Phase 1 trial of IBIO-600 in Australia in June 2026 and has completed dosing in all four single …
The note also looks at late fees. A hypothetical 35% reduction in late fees would imply an average earnings downside of roughly 9% across the major issuers, with Bread Financial again the most sensitive. Late fees are an important source ofRevenuefor issuers serving subprime …